Extracorporeal Photopheresis in Steroid-Refractory Acute or Chronic Graft-versus-Host Disease: Results of a Systematic Review of Prospective Studies

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 11, 2014, Pages 1677-1686

  Abu Dalle, Iman ^a   Reljic, Tea ^b   Nishihori, Taiga ^b,c   Antar, Ahmad ^a   Bazarbachi, Ali ^a   Djulbegovic, Benjamin ^b,c   Kumar, Ambuj ^b   Kharfan Dabaja, Mohamed A ^b,c  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Acute; Chronic; Extracorporeal photopheresis; Graft versus host disease

Indexed keywords

STEROID;

ACUTE GRAFT VERSUS HOST DISEASE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL EFFECTIVENESS; COCHRANE LIBRARY; EXTRACORPOREAL PHOTOPHERESIS; GASTROINTESTINAL TRACT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG; MEDLINE; MORTALITY; PROSPECTIVE STUDY; PUVA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SKIN; SYSTEMATIC REVIEW; ACUTE DISEASE; ADULT; CHILD; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; MALE; MIDDLE AGED; PROCEDURES; YOUNG ADULT;

ACUTE DISEASE; ADULT; CHILD; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; PHOTOPHERESIS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84908068270     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.05.017     Document Type: Review

References (48)

1. van Besien K. Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence. Hematology Am Soc Hematol Educ Program 2013, 2013:56-62.
2. Kharfan-Dabaja M.A., Bazarbachi A. Hematopoietic stem cell allografting for chronic lymphocytic leukemia: a focus on reduced-intensity conditioning regimens. Cancer Control 2012, 19:68-75.
3. Kunter G., Perkins J.B., Pidala J., et al. Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission. Bone Marrow Transplant 2014, 49:11-16.
4. Ayas M., Nassar A., Hamidieh A.A., et al. Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure. Bone Marrow Transplant 2013, 48:1168-1172.
5. Matos-Fernandez N.A., Abou Mourad Y.R., Caceres W., Kharfan-Dabaja M.A. Current status of allogeneic hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria. Biol Blood Marrow Transplant 2009, 15:656-661.
6. Peffault de Latour R., Porcher R., Dalle J.H., et al. Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood 2013, 122:4279-4286.
7. Bacigalupo A., Socie G., Lanino E., et al. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party. Haematologica 2010, 95:976-982.
8. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
9. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
10. Deeg H.J. How I treat refractory acute GVHD. Blood 2007, 109:4119-4126.
11. Lee S.J., Flowers M.E. Recognizing and managing chronic graft-versus-host disease. Hematology Am Soc Hematol Educ Program 2008, 134-141.
12. Anasetti C., Logan B.R., Lee S.J., et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. NEngl J Med 2012, 367:1487-1496.
13. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. JClin Oncol 2005, 23:5074-5087. Stem Cell Trialists' Collaborative Group.
14. Jagasia M., Arora M., Flowers M.E., et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood 2012, 119:296-307.
15. Flowers M.E., Inamoto Y., Carpenter P.A., et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 2011, 117:3214-3219.
16. Mielcarek M., Storer B.E., Boeckh M., et al. Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes. Blood 2009, 113:2888-2894.
17. Pidala J., Anasetti C. Glucocorticoid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant 2010, 16:1504-1518.
18. Kharfan-Dabaja M.A., Mhaskar A.R., Djulbegovic B., et al. Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis. Biol Blood Marrow Transplant 2009, 15:1005-1013.
19. Pidala J., Kim J., Roman-Diaz J., et al. Pentostatin as rescue therapy for glucocorticoid-refractory acute and chronic graft-versus-host disease. Ann Transplant 2010, 15:21-29.
20. Hoda D., Pidala J., Salgado-Vila N., et al. Sirolimus for treatment of steroid-refractory acute graft-versus-host disease. Bone Marrow Transplant 2010, 45:1347-1351.
21. Martin P.J., Rizzo J.D., Wingard J.R., et al. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2012, 18:1150-1163.
22. Smith E.P., Sniecinski I., Dagis A.C., et al. Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease. Biol Blood Marrow Transplant 1998, 4:27-37.
23. Salvaneschi L., Perotti C., Zecca M., et al. Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion 2001, 41:1299-1305.
24. Seaton E.D., Szydlo R.M., Kanfer E., et al. Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. Blood 2003, 102:1217-1223.
25. Foss F.M., DiVenuti G.M., Chin K., et al. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant 2005, 35:1187-1193.
26. Garban F., Drillat P., Makowski C., et al. Extracorporeal chemophototherapy for the treatment of graft-versus-host disease: hematologic consequences of short-term, intensive courses. Haematologica 2005, 90:1096-1101.
27. Greinix H.T., Knobler R.M., Worel N., et al. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Haematologica 2006, 91:405-408.
28. Kanold J., Merlin E., Halle P., et al. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature. Transfusion 2007, 47:2276-2289.
29. Calore E., Calo A., Tridello G., et al. Extracorporeal photochemotherapy may improve outcome in children with acute GVHD. Bone Marrow Transplant 2008, 42:421-425.
30. Flowers M.E., Apperley J.F., van Besien K., et al. Amulticenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood 2008, 112:2667-2674.
31. Alcindor T., Gorgun G., Miller K.B., et al. Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease. Blood 2001, 98:1622-1625.
32. Goussetis E., Varela I., Tsirigotis P. Update on the mechanism of action and on clinical efficacy of extracorporeal photopheresis in the treatment of acute and chronic graft versus host disease in children. Transfus Apher Sci 2012, 46:203-209.
33. Edelson R.L. Mechanistic insights into extracorporeal photochemotherapy: Efficient induction of monocyte-to-dendritic cell maturation. Transfus Apher Sci 2014, 50:322-329.
34. Couriel D.R., Hosing C., Saliba R., et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 2006, 107:3074-3080.
35. Higgins JPT AD, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT GS, ed. Cochrane Handbook for Systematic Reviews of Interventions Version 510: The Cochrane Collaboration;2011.
36. Wells G.A., Shea B., O'Connell D., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses 2013, Ontario The Ottawa Health Research Institute, Ottawa, http://www.ohri.ca/programs/clinical_epidemiology/nosgen.doc. Accessed March 10, 2013.
37. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
38. Stuart A., Ord K. Kendall's advanced theory of statistics 1994, Wiley.
39. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535.
40. Andreu G., Leon A., Heshmati F., et al. Extracorporeal photochemotherapy: evaluation of two techniques and use in connective tissue disorders. Transfus Sci 1994, 15:443-454.
41. Edelson R., Berger C., Gasparro F., et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. NEngl J Med 1987, 316:297-303.
42. Peritt D. Potential mechanisms of photopheresis in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006, 12:7-12.
43. Maeda A., Schwarz A., Kernebeck K., et al. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. JImmunol 2005, 174:5968-5976.
44. Lamioni A., Parisi F., Isacchi G., et al. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells invitro and regulatory T cells invivo. Transplantation 2005, 79:846-850.
45. Berger C., Hoffmann K., Vasquez J.G., et al. Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy. Blood 2010, 116:4838-4847.
46. Pierelli L., Perseghin P., Marchetti M., et al. Extracorporeal photopheresis for the treatment of acute and chronic graft-versus-host disease in adults and children: best practice recommendations from an Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and Italian Group for Bone Marrow Transplantation (GITMO) consensus process. Transfusion 2013, 53:2340-2352.
47. Wolff D., Schleuning M., von Harsdorf S., et al. Consensus Conference on Clinical Practice in Chronic GVHD: second-line treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2011, 17:1-17.
48. Lucid C.E., Savani B.N., Engelhardt B.G., et al. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT. Bone Marrow Transplant 2011, 46:426-429.